Nitric Oxide as a Target for Phytochemicals in Anti-Neuroinflammatory Prevention Therapy.
Lalita SubediBhakta Prasad GaireAmna ParveenSun Yeou KimPublished in: International journal of molecular sciences (2021)
Nitric oxide (NO) is a neurotransmitter that mediates the activation and inhibition of inflammatory cascades. Even though physiological NO is required for defense against various pathogens, excessive NO can trigger inflammatory signaling and cell death through reactive nitrogen species-induced oxidative stress. Excessive NO production by activated microglial cells is specifically associated with neuroinflammatory and neurodegenerative conditions, such as Alzheimer's and Parkinson's disease, amyotrophic lateral sclerosis, ischemia, hypoxia, multiple sclerosis, and other afflictions of the central nervous system (CNS). Therefore, controlling excessive NO production is a desirable therapeutic strategy for managing various neuroinflammatory disorders. Recently, phytochemicals have attracted considerable attention because of their potential to counteract excessive NO production in CNS disorders. Moreover, phytochemicals and nutraceuticals are typically safe and effective. In this review, we discuss the mechanisms of NO production and its involvement in various neurological disorders, and we revisit a number of recently identified phytochemicals which may act as NO inhibitors. This review may help identify novel potent anti-inflammatory agents that can downregulate NO, specifically during neuroinflammation and neurodegeneration.
Keyphrases
- nitric oxide
- cell death
- weight gain
- multiple sclerosis
- amyotrophic lateral sclerosis
- anti inflammatory
- hydrogen peroxide
- oxidative stress
- cell cycle arrest
- induced apoptosis
- inflammatory response
- traumatic brain injury
- stem cells
- lps induced
- working memory
- climate change
- endothelial cells
- spinal cord injury
- risk assessment
- neuropathic pain
- cerebrospinal fluid
- spinal cord
- signaling pathway
- cognitive impairment
- pi k akt
- cell therapy
- mild cognitive impairment